... 項作骨幹,並透過身(Bio)、心(Psycho)、社(Social)的健康模型,鼓勵小學生和家長在假期的六周內 ...全文
今日信報時事評論張鳳儀 蘇穎欣 葉兆輝2022年03月15日
基因及診斷檢測公司Prenetics夥拍ACON Bio,在港推出家用新冠病毒SARS-CoV-2抗原檢測Fl ...全文
... 培育計劃(INCU-BIO),不僅為初創提供資金和科研辦公室空間,更協助他們連結投資者,讓他們明白市場需求,教 ...全文
... 育計劃」(Incu-Bio),除了提供400萬港元財政補貼,還有共享實驗室、辦公空間等配套。 此外,科技園公司 ...全文
今日信報財經新聞StartupBeat 創科鬥室2021年10月20日
... rooted in bio-medical issues that require a multitude o ...全文
今日信報時事評論EJ InsightBrian Wong2021年10月16日
... rooted in bio-medical issues that require a multitude of responses. Secondly, it’s one thing to say that we “care” about mental health. It’s another to move from the general to the particular – i.e. t ...More
EJ Insight2021-10-13
... 利用粟米研發生物基(Bio-based)環保物料,鄭嘉泳分析:「造出來的東西,壽命跟塑膠無大分別。」 他指出, ...全文
今日信報財經新聞StartupBeat 創科鬥室2021年10月04日
... 啲數學唔係咁叻,就揀Bio(生物)。(大學)畢業讀埋碩士,由此『跌落陷阱』,(何出此言?)之後一直讀博士、做研 ...全文
... Translate Bio生物製藥廠,本次行動是集團連續第2個月收購美國藥廠。 根據協議,收購Kadmon每股 ...全文
... help the bio-technology IPOs, most of which were loss-making but priced at high valuations attractive enough for owners to sell some of their stakes to the public. Once bitten, twice shy. Would inves ...More
EJ Insight2021-08-25
路透引述消息人士稱,法國賽諾菲藥廠(Sanofi)已經提出收購美國Translate Bio生物製藥廠的建議, ...全文
... 收購南韓Huons Bio的25.4%股權。 獲核心肉毒資產 實現協同效應 Huons Bio前身是南韓知名藥 ...全文
... ase to be bio- and safety hazards, that these caged hom ...全文
今日信報時事評論EJ InsightBrian Wong2021年06月19日
... ase to be bio- and safety hazards, that these caged homes – whilst compact – could at least ensure that their tenants are not rendered susceptible to contagious diseases and active jeopardy. In an ide ...More
EJ Insight2021-06-18
醫療設備製造商上海百心安生物技術(Shanghai Bio-heart Biological Technolo ...全文
... 尼國營製藥企業PT Bio Farma,與科興就採購1.2億劑新冠疫苗進行談判。Bio Farma亦將開展自費 ...全文
Climate change and biodiversity loss are the most pressing challenges of our time, so all responsible political leaders must offer long-term policies for confronting them effectively. We need clear st ...More
EJ Insight2021-05-20
... 生物再生生命技術」(bio-regenerative technologies)出現更大量需求。 歐盟和東盟可 ...全文
... h as Wuxi Bio, Xiaomi and Meituan lost ground year to date. All three of them roughly tripled last year, but year to date, Wuxi Bio was down 4 percent, Xiaomi fell about 22 percent, and Meituan was ma ...More
EJ Insight2021-03-31